Crossref
MHRA regulatory considerations for the quality of mRNA products
Nucleic Acid Insights · 2024
DOI: 10.18609/nai.2024.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Insights, 2024. Verfasst von Ka-Wai Wan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wan, K., & Galaway, F. (2024). MHRA regulatory considerations for the quality of mRNA products. Nucleic Acid Insights. https://doi.org/10.18609/nai.2024.020
Vancouver
Wan K, Galaway F. MHRA regulatory considerations for the quality of mRNA products. Nucleic Acid Insights. 2024. doi:10.18609/nai.2024.020
BibTeX
@article{Wan2024,
author = {Wan, Ka-Wai and Galaway, Francis},
title = {MHRA regulatory considerations for the quality of mRNA products},
journal = {Nucleic Acid Insights},
year = {2024},
doi = {10.18609/nai.2024.020}
}
EUVIMED